CJC-1295 DAC

CJC-1295 DAC
US$80.00

COMES WITH BACTERIA WATER

5mg 80$ per vial

Information

CJC-1295 DAC is a synthetic peptide designed to mimic the effects of growth hormone-releasing hormone (GHRH). It is commonly studied for its ability to stimulate the release of growth hormone (GH) from the pituitary gland and its extended half-life due to the inclusion of a Drug Affinity Complex (DAC). This complex enables CJC-1295 DAC to remain active in the body for 7–10 days, significantly longer than non-DAC versions.

How It Works

CJC-1295 DAC binds to receptors in the anterior pituitary gland, stimulating the release of growth hormone. The DAC component binds to albumin in the bloodstream, extending its stability and bioavailability. This prolonged action allows for fewer injections compared to other peptides.

When used in conjunction with growth hormone secretagogues (GHS), such as GHRP-6, GHRP-2, or Ipamorelin, it enhances the natural pulsatile release of GH, leading to amplified benefits.

Potential Benefits

  1. Muscle Growth and Recovery

    • Increased GH levels support protein synthesis and muscle hypertrophy.
    • Promotes faster recovery from physical exertion and injuries.

  2. Fat Loss

    • GH enhances lipolysis, promoting the breakdown of stored fat.
    • Leads to improved body composition over time.

  3. Anti-Aging Effects

    • Higher GH levels may reduce signs of aging, such as improved skin elasticity and reduced wrinkles.
    • Helps maintain bone density and joint health.

  4. Improved Sleep

    • GH secretion is closely linked to deep sleep, potentially improving sleep quality.

  5. Enhanced Physical Performance

    • Boosts energy levels and endurance.

Potential Side Effects

Although generally well-tolerated, CJC-1295 DAC may lead to side effects, particularly if misused or taken in excessive doses. Commonly reported issues include:

  • Water retention.
  • Joint pain.
  • Numbness or tingling in extremities.
  • Headaches.
  • Increased hunger.

Rare but severe complications include overproduction of GH, which can lead to conditions like acromegaly or insulin resistance.

Dosage and Administration

CJC-1295 DAC is typically administered via subcutaneous injection. The extended half-life means injections are usually required only 1–2 times per week, depending on individual goals and recommendations.

Typical Dosages:

  • Range from 1–2 mg per week, but precise protocols vary based on research objectives.